published Jul 8, 2018 5:00:00 PM, by Vinicy Chan and Crystal Tse (Bloomberg) — Investment bankers in Hong Kong are catching biotech fever. At least seven senior bankers and analysts from top-tier securities firms have quit to join biotechnology companies in the city since December, responding to the industry’s growing